CIBC Private Wealth Group
RXST icon

CIBC Private Wealth Group’s RxSight RXST Stock Holding History

CIBC Private Wealth Group’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,690
Closed -$48K – 3276
2025
Q2 		$48K Sell
3,690
-30
-0.8% -$451 ﹤0.01% 1680
2025
Q1 		$55.8K Sell
3,720
-5,943
-62% -$177K ﹤0.01% 1597
2024
Q4 		$333K Buy
+9,663
New +$436K ﹤0.01% 982
2024
Q2 		– Sell
-443
Closed -$22.4K – 3277
2024
Q1 		$22.4K Buy
+443
New +$21.7K ﹤0.01% 2006

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC Private Wealth Group's RXST Position: Q3 2025 in Review

CIBC Private Wealth Group sold out of RxSight (RXST) in Q3 2025, closing a stake of 3,690 shares — an estimated $48K sold.

CIBC Private Wealth Group first reported a position in RXST in Q1 2024 and held it in 4 quarters. The position peaked at $333K in Q4 2024. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • CIBC Private Wealth Group reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 3,690 RxSight shares in Q3 2025, an estimated $48K.
  • CIBC Private Wealth Group first reported a position in RxSight in Q1 2024 and held it in 4 quarters.
  • CIBC Private Wealth Group's RxSight position peaked at $333K in Q4 2024.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on CIBC Private Wealth Group's 13F filing for Q3 2025, filed 24 Nov 2025.